Azactam and Creon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azactam (aztreonam) and Creon (pancrelipase (amylase;lipase;protease)). Common drug interactions include premature delivery among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Azactam and Creon. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Azactam?

Azactam has active ingredients of aztreonam. eHealthMe is studying from 1,044 Azactam users. Check the latest studies of Azactam.

What is Creon?

Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.



On Aug, 01, 2026

40 people who take Azactam and Creon together, and have interactions are studied.

Azactam and Creon drug interactions.

What are the common drug interactions of Azactam and Creon, by gender? *:

female:

  1. Premature delivery
  2. Pulmonary haemorrhage (acute bleeding from the lung)
  3. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  4. Maternal exposure during pregnancy (use of substance during pregnancy)
  5. Neonatal respiratory distress syndrome (a serious medical condition where a newborn baby's lungs cannot provide their body with enough oxygen)
  6. Premature baby

male:

  1. Cough
  2. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  4. Night sweats (sweating in night)
  5. Productive cough
  6. Pruritus (severe itching of the skin)
  7. Pseudomonas test positive
  8. Pyrexia (fever)
  9. Secretion discharge
  10. Sputum discoloured

What are the common drug interactions of Azactam and Creon, by age (0-1 to 60+)? *:

0-1:

  1. Pulmonary haemorrhage (acute bleeding from the lung)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Neonatal respiratory distress syndrome (a serious medical condition where a newborn baby's lungs cannot provide their body with enough oxygen)
  4. Premature baby

2-9:

  1. Abdominal pain
  2. Cough
  3. Flushing (the warm, red condition of human skin)
  4. Malaise (a feeling of general discomfort or uneasiness)

10-19:

n/a

20-29:

  1. Premature delivery
  2. Maternal exposure during pregnancy (use of substance during pregnancy)

30-39:

  1. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  2. Asthenia (weakness)
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  4. Night sweats (sweating in night)
  5. Productive cough
  6. Pruritus (severe itching of the skin)
  7. Pseudomonas test positive
  8. Pyrexia (fever)
  9. Secretion discharge
  10. Sputum discoloured

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 28 people, 70.00%
  2. Infection: 23 people, 57.50%
  3. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 7 people, 17.50%
  4. Wheezing (a high-pitched whistling sound made while you breath): 6 people, 15.00%
  5. Migraine Without Aura (headache without neurological problems): 6 people, 15.00%
  6. Bacterial Infection: 6 people, 15.00%
  7. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 6 people, 15.00%
  8. Constipation: 6 people, 15.00%
  9. Cough: 6 people, 15.00%
  10. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 6 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take Azactam and Creon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azactam and Creon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azactam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Creon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azactam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Creon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aztreonam and pancrelipase (amylase;lipase;protease) (the active ingredients of Azactam and Creon, respectively), and Azactam and Creon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: